HealthTech.euabout 3 hours ago
bit.bio Raises $25M Series D Funding
2 min read
Cambridge biotech bit.bio raised $25 million in Series D funding on Wednesday, ten months after its Series C. Backed by M&G Investments and Dr Jonathan Milner, the company plans to expand cell types and customer base rather than build new infrastructure.
Level
Hype check
Tap to vote and see what everyone thinks.
